Form 4: Insmed Director David Brennan Receives RSU Grant

Insmed Inc. director David R. Brennan was granted 3,305 restricted stock units as part of his annual compensation.

Summary

• Director David R. Brennan acquired 3,305 restricted stock units (RSUs) on May 13, 2026.
• Each RSU represents a contingent right to receive one share of Insmed Inc. common stock.
• The RSUs vest in full on the first anniversary of the grant date, subject to continued board service and meeting attendance requirements.
• Following this transaction, David R. Brennan directly owns 64,238 shares of common stock, with an additional 60,000 shares held indirectly via a spouse's revocable trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• Director alignment with shareholder interests is maintained through equity-based compensation.
• The grant is subject to performance-based conditions, specifically a 75% board meeting attendance requirement.

Negatives

• None identified; this is a standard director compensation event.

Risks

• Vesting is contingent upon the director remaining on the Board of Directors until the earlier of the first anniversary or the next annual shareholder meeting.

Future Outlook

The RSUs are scheduled to vest on May 13, 2027, provided the director meets the specified service and attendance criteria.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice in the biotechnology sector to ensure long-term alignment between board members and shareholders.

Comparison to Industry Standards

• The use of RSUs for director compensation is consistent with standard practices among mid-cap and large-cap biopharmaceutical companies.
• The inclusion of attendance-based vesting criteria is a common governance mechanism to ensure active board participation.

Corporate Governance

Stakeholder Impact

• Shareholders: Minimal impact; represents standard director compensation.

Next Steps

• Vesting of the 3,305 RSUs on May 13, 2027.

Key Dates

Keywords

Insmed, INSM, Director Compensation, Restricted Stock Units, Insider Transaction, Form 4